DADATA·ANALYSIS
FREE
company · cik 1133416

GALECTIN THERAPEUTICS INC

GALTNasdaqSIC 2834public
financials · annual · usd2026
Net income-$30.8M
Total assets$19.5M
Total liabilities$145.7M
Equity-$127.9M
Operating cash-$23.9M
money-flow · companies

No customer / supplier links anchored.

commodity exposure

No commodity exposure anchored.

places · hq + contracts1